| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | $10,3700 | +3,08% | $317,37M | $81,64K | |
FUND Sprott Focus Trust, Inc. | $10,8700 | +0,56% | $317,19M | $16,86K | |
FATE Fate Therapeutics, Inc. | $2,5400 | +4,10% | $317,04M | $2,31M | |
NMRA Neumora Therapeutics, Inc. Common Stock | $1,4800 | -2,95% | $316,83M | $401,64K | |
GALT Galectin Therapeutics Inc. | $4,0000 | +3,09% | $316,66M | $163,71K | |
NREF NexPoint Real Estate Finance, Inc. | $17,3500 | -1,36% | $316,64M | $26,74K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | $10,8100 | -0,19% | $316,34M | $4,39K | |
PSBD Palmer Square Capital BDC Inc. | $10,4300 | +0,48% | $316,32M | $126,61K | |
| $3,5500 | +14,15% | $316,09M | $2,35M | |
| $6,5300 | +1,56% | $315,88M | $37,18K | |
SMTI Sanara MedTech Inc. Common Stock | $34,7300 | +1,02% | $315,59M | $375,60K | |
MLP Maui Land & Pineapple Co. | $16,0600 | +1,90% | $315,56M | $8,30K | |
AFB Alliance National Municipal Income Fund, Inc. | $10,9400 | +0,09% | $315,33M | $39,82K | |
| $41,4500 | +1,12% | $315,30M | $15,63K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | $10,5400 | +0,09% | $315,30M | $181,45K | |
